MX2010006516A - Composiciones farmaceuticas. - Google Patents
Composiciones farmaceuticas.Info
- Publication number
- MX2010006516A MX2010006516A MX2010006516A MX2010006516A MX2010006516A MX 2010006516 A MX2010006516 A MX 2010006516A MX 2010006516 A MX2010006516 A MX 2010006516A MX 2010006516 A MX2010006516 A MX 2010006516A MX 2010006516 A MX2010006516 A MX 2010006516A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- compositions
- granules
- tablet
- optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describen composiciones en donde ciertos compuestos de unión de receptores de la hormona tiroides se formulan junto con un relleno básico. Tal formulación actúa para prevenir la formación de productos de reacción indeseados. Las composiciones pueden formarse en gránulos o en una tableta que pueden opcionalmente estar recubiertos entéricamente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0724478.3A GB0724478D0 (en) | 2007-12-14 | 2007-12-14 | Pharmaceutical compositions |
PCT/EP2008/010636 WO2009077147A2 (en) | 2007-12-14 | 2008-12-15 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010006516A true MX2010006516A (es) | 2010-08-04 |
Family
ID=39048158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010006516A MX2010006516A (es) | 2007-12-14 | 2008-12-15 | Composiciones farmaceuticas. |
Country Status (20)
Country | Link |
---|---|
US (1) | US20110014243A1 (es) |
EP (1) | EP2231121B1 (es) |
JP (1) | JP2011506373A (es) |
KR (1) | KR20100103824A (es) |
CN (1) | CN101896167B (es) |
AT (1) | ATE518525T1 (es) |
AU (1) | AU2008337924A1 (es) |
BR (1) | BRPI0821128A2 (es) |
CA (1) | CA2707453A1 (es) |
DK (1) | DK2231121T3 (es) |
ES (1) | ES2369168T3 (es) |
GB (1) | GB0724478D0 (es) |
HK (1) | HK1143079A1 (es) |
IL (1) | IL206138A0 (es) |
MX (1) | MX2010006516A (es) |
NZ (1) | NZ585956A (es) |
PL (1) | PL2231121T3 (es) |
RU (1) | RU2010129081A (es) |
WO (1) | WO2009077147A2 (es) |
ZA (1) | ZA201004094B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2608878A4 (en) | 2010-08-23 | 2017-11-15 | President and Fellows of Harvard College | Acoustic waves in microfluidics |
JP2013538212A (ja) * | 2010-08-23 | 2013-10-10 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | 薬物送達および他の用途のための粒子 |
EP2609910A1 (en) | 2011-12-30 | 2013-07-03 | Deva Holding Anonim Sirketi | Formulations of eprotirome |
DK2695611T3 (en) | 2012-08-06 | 2015-01-05 | Wolff August Gmbh & Co Kg Arzneimittel Dr | Eprotirome for use in the prevention and / or treatment of hair disorders and their compositions |
EP2954009A1 (de) | 2013-02-08 | 2015-12-16 | Basf Se | Herstellung von anorganisch-organischen kompositmaterialien durch reaktive sprühtrocknung |
US9138381B2 (en) | 2013-02-08 | 2015-09-22 | Basf Se | Production of inorganic-organic composite materials by reactive spray-drying |
US10258987B2 (en) | 2014-06-26 | 2019-04-16 | President And Fellows Of Harvard College | Fluid infection using acoustic waves |
LT3341116T (lt) | 2015-08-27 | 2022-05-25 | President And Fellows Of Harvard College | Rūšiavimo naudojant akustines bangas būdas |
JP6168673B2 (ja) | 2015-10-07 | 2017-07-26 | 協和発酵キリン株式会社 | アリールアルキルアミン化合物含有医薬組成物 |
KR102488488B1 (ko) * | 2015-10-07 | 2023-01-12 | 쿄와 기린 가부시키가이샤 | 아릴알킬아민 화합물 함유 의약 조성물 |
US11701658B2 (en) | 2019-08-09 | 2023-07-18 | President And Fellows Of Harvard College | Systems and methods for microfluidic particle selection, encapsulation, and injection using surface acoustic waves |
WO2024165571A2 (en) | 2023-02-06 | 2024-08-15 | E-Therapeutics Plc | Inhibitors of expression and/or function |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001060784A1 (en) * | 2000-02-17 | 2001-08-23 | Bristol-Myers Squibb Co. | Aniline-derived ligands for the thyroid receptor |
ITMI20011401A1 (it) * | 2001-07-02 | 2003-01-02 | Altergon Sa | Formulazioni farmaceutiche per ormoni tiroidei |
GB0606212D0 (en) * | 2006-03-28 | 2006-05-10 | Karobio Ab | Pharmaceutical compositions |
-
2007
- 2007-12-14 GB GBGB0724478.3A patent/GB0724478D0/en not_active Ceased
-
2008
- 2008-12-15 BR BRPI0821128-0A patent/BRPI0821128A2/pt not_active IP Right Cessation
- 2008-12-15 WO PCT/EP2008/010636 patent/WO2009077147A2/en active Application Filing
- 2008-12-15 DK DK08863025.6T patent/DK2231121T3/da active
- 2008-12-15 RU RU2010129081/15A patent/RU2010129081A/ru not_active Application Discontinuation
- 2008-12-15 US US12/735,018 patent/US20110014243A1/en not_active Abandoned
- 2008-12-15 AU AU2008337924A patent/AU2008337924A1/en not_active Abandoned
- 2008-12-15 KR KR1020107015612A patent/KR20100103824A/ko not_active Application Discontinuation
- 2008-12-15 PL PL08863025T patent/PL2231121T3/pl unknown
- 2008-12-15 CA CA2707453A patent/CA2707453A1/en not_active Abandoned
- 2008-12-15 AT AT08863025T patent/ATE518525T1/de active
- 2008-12-15 MX MX2010006516A patent/MX2010006516A/es unknown
- 2008-12-15 JP JP2010537329A patent/JP2011506373A/ja active Pending
- 2008-12-15 CN CN2008801209214A patent/CN101896167B/zh not_active Expired - Fee Related
- 2008-12-15 NZ NZ585956A patent/NZ585956A/en not_active IP Right Cessation
- 2008-12-15 ES ES08863025T patent/ES2369168T3/es active Active
- 2008-12-15 EP EP08863025A patent/EP2231121B1/en active Active
-
2010
- 2010-06-02 IL IL206138A patent/IL206138A0/en unknown
- 2010-06-08 ZA ZA2010/04094A patent/ZA201004094B/en unknown
- 2010-10-13 HK HK10109671.5A patent/HK1143079A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BRPI0821128A2 (pt) | 2015-06-16 |
DK2231121T3 (da) | 2011-10-24 |
CN101896167B (zh) | 2012-08-15 |
AU2008337924A1 (en) | 2009-06-25 |
ZA201004094B (en) | 2011-02-23 |
HK1143079A1 (en) | 2010-12-24 |
WO2009077147A2 (en) | 2009-06-25 |
ATE518525T1 (de) | 2011-08-15 |
GB0724478D0 (en) | 2008-01-30 |
EP2231121B1 (en) | 2011-08-03 |
ES2369168T3 (es) | 2011-11-28 |
IL206138A0 (en) | 2010-11-30 |
NZ585956A (en) | 2011-11-25 |
CN101896167A (zh) | 2010-11-24 |
CA2707453A1 (en) | 2009-06-25 |
US20110014243A1 (en) | 2011-01-20 |
RU2010129081A (ru) | 2012-01-20 |
PL2231121T3 (pl) | 2011-12-30 |
KR20100103824A (ko) | 2010-09-28 |
EP2231121A2 (en) | 2010-09-29 |
JP2011506373A (ja) | 2011-03-03 |
WO2009077147A3 (en) | 2010-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1143079A1 (en) | Pharmaceutical compositions | |
EP2045251A4 (en) | COMPOUNDS WHICH CAN INCLUDE THE UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS | |
GB0606212D0 (en) | Pharmaceutical compositions | |
HUP0600728A2 (en) | Pharmaceutical compositions containing rosuvastatin potassium | |
IL233677A (en) | Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition | |
IL196167A0 (en) | Bicyclic compounds and pharmaceutical compositions containing the same | |
ZA201004214B (en) | Dipeptidyl peptidase-iv inhibiting compounds,methods of preparing the same,and pharmaceutical compositions containing the same as active agent | |
IL204520A (en) | Oxadiazole diaryl compounds, their preparations and pharmaceutical preparations containing them | |
IL194800A0 (en) | Pre-mixed, ready-to-use pharmaceutical compositions | |
LT2966175T (lt) | Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato | |
IL212057A (en) | Use of granulated mesalamine containing remedies for preservation of ulcerative colitis | |
HUP0700269A2 (en) | Pyrimidinyl-piperazines useful as d3/d2 receptor ligands, pharmaceutical compositions containing them and their use | |
PL1886686T3 (pl) | Kompozycja farmaceutyczna zawierająca pirośluzan mometazonu | |
IL216361A0 (en) | Anti-cancer compound and pharmaceutical composition containing the same | |
ATE533477T1 (de) | Pharmazeutische zusammensetzungen enthaltend irbesartan | |
GB0716907D0 (en) | Pharmaceutical powder compositions | |
PT2461802T (pt) | Composições granulares de libertação controlada contendo mesalazina e processo para o seu fabrico | |
EP2064950A4 (en) | POWDERY AGROCHEMICAL COMPOSITION | |
WO2011017346A3 (en) | Fast-acting naproxen composition with reduced gastrointestinal effects | |
HU0700755D0 (en) | Pharmaceutical compositions containing capsaicionid | |
UA27344U (en) | Use of pollentar pharmaceutical composition as cerebroprotective agent | |
MX2009012458A (es) | Forma de dosificacion oral que permite una rapida absorcion de un farmaco. | |
TWI368614B (en) | Araminone compounds, their preparations, pharmaceutical compositions containing them, and their uses | |
NZ610638A (en) | Pharmaceutical compositions comprising radezolid |